Sternal Closure Systems Industry Was Dominated by North America

The total value of the sternal closure systems industry was USD 2,212.3 million in 2022, which will reach USD 3,323.4 million by 2030, at a growth rate of 5.2% in the years to come.

Get the sample pages of this report: https://bit.ly/3zkjshV

The product segment is divided into bone cement and closure devices, of which the latter will dominate the industry; with 60% share, in the recent past.

The key factors responsible for the dominance include the initiation of new items and the rise in the per capita spending on surgery in both developing and developed nations.

As opposed to bone cement, these devices have witnessed fewer problems after surgery, along with infections. Moreover, patients recover quicker with those devices. Furthermore, this category is powered by the efforts made by the mavens for introducing new methods and products for closure of the sternum.

Media sternotomy dominated the industry with respect to procedure segment, with around 55% share. For easily reaching the heart, lungs, and nearby structures throughout coronary artery bypass surgery and heart valve replacement surgery, this process is the regularly performed osteotomy globally.

This is due to the fact that it reduces the probabilities of problems,  including hardware complications, osseous issues, including wire rotation or migration; and post-operative contaminations. The incision similarly offers access to both the pleural spaces, making it helpful for numerous thoracic procedures, such as the treatment of esophagectomy and retrosternal goiters.

Germany is booming in Europe. This has a lot to do to the fact that the nation's healthcare budget has increased, it is applying cutting-edge technologies, the government is becoming aware of the requirement for early diagnosis and effective treatment of the diseases, advantageous reimbursement strategies are offered, and healthcare professionals are rapidly accepting advanced technologies for ensuring better surgical results.

It is because of the rise in the number of cardiothoracic surgeries, the demand for sternal closure systems will rise significantly in the future.

Read More

Pharmacy Automation Industry IS Dominated by North America

In 2021, the pharmacy automation industry was USD 5,782.1, which will touch USD 10,337.7 million by 2030, growing at a CAGR of 7.5% during 2022–2030, as per a market research report by P&S Intelligence.

To learn more about this report: https://bit.ly/3lTvkVe

The industry will grow more rapidly in developing nations, comprising of a considerable elderly population. Additionally, the rate at which the aging of the population is escalating is much higher as compared to the past. As per WHO, one in six people globally will be aged 60 or above by the end of this decade.

The foremost reason for hospital readmissions is the errors related to drug- and distribution issues. Throughout the process of production, distribution, and administration of pharmaceuticals, the misperception resulting from similar labels and prescriptions, insecure procedures of drug storage, and poor order communication among doctors and pharmacists  are key reasons for medication errors.

One of the most-effective ways of reducing these glitches these errors is with the help of automated systems. In the years gone by, ADCs and ADMs have effectively decreased the count of errors associated with medication dispensing in hospitals.

Medication dispensing & storage system s had the largest share with about 45%. This has a lot to do with these systems' improved safety features and accuracy in drug distribution, which decrease the possibility of patients getting incorrect medicines.

Moreover, they support in reducing the costs and making the management of inventory more efficient, by regulating storage. Patients receiving the wrong prescriptions not just are susceptible to health issues, but also considerable financial crunches.

Retail pharmacies have substantial share of the pharmacy automation market. The increase in the acceptance of retail dispensaries and the reduction of price brought by the automation of their procedures are accountable for this.

The growth of the industry is also because of the fact that throughout the pandemic, only grocery shops, healthcare facilities, and a few essential setups were permitted to open. This, in line, gave players the idea of investing in this industry, as it is a future business alternative.

Inpatient pharmacy accounted for the largest share of 40%, in the recent past. This was because of the increasing responsibility of healthcare providers for decreasing the frequency of medication distribution errors and, eventually, disregard them to the core.

North America dominated the industry , accounting for half of the total revenue. The main reasons for this are the developed healthcare system, presence of industry mavens, enhancements in methodologies of patient management, and disposition of cutting-edge practice management systems.

It is because of the rising requirement for specialized drugs all over the world, the demand for pharmacy automation services will further increase in the coming years.

Read More

North America Is Dominating Contrast Media Industry

In 2022, the contrast media market was worth around USD 5,231.4 million, and it is projected to advance at a 4.9% CAGR from 2022 to 2030, hitting USD 7,647.7 million by 2030, according to P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3JWAcAM

Diagnostic imaging procedures, such as ultrasound, X-ray, and pioneering modalities, including CT and MRI are turning progressively common with the growing occurrence of intricate comorbidities and chronic illnesses. Furthermore, such modalities are gradually improving and becoming more exact to diagnose these circumstances, and contrast media is a main product that improves image quality.

The occurrence of chronic conditions has surged over the years because of the increasing deskbound lifestyles of individuals. Furthermore, there has been a substantial intake of high-calorie foods and insufficient physical activity, which are ultimately contributing to the growth of chronic diseases.

Key players in the market have a ton of opportunities because of surging R&D events in novel contrast agents and the making of innovative applications for them.

For example, to change the frequently-used gadolinium-based imaging agents, Gang Han, PHD., professor of molecular pharmacology and biochemistry, has got seed capital from the UMass Technology Development Fund to examine a safer, novel biogenic family of contrast agents for magnetic resonance imaging.

In 2022, based on modality, the X-ray/CT category held the largest contrast media market share, at approximately 50%. This can be ascribed to the growth in the frequency of communicable and non-communicable diseases in the past few years. As per the study, there has been a noteworthy increase in the count of CT scans during the COVID-19 pandemic.

In 2022, based on application, cardiovascular disorders held the largest market share, of around 40%, credited to the increasing number of elder populations. According to a study conducted by the WHO, the major cause of demise globally is cardiovascular diseases, which claim 17.9 million lives yearly. Additionally, the pace at which the aging populace is increasing is significantly higher than in the past.

In 2022, according to the regional analysis, North America held the largest market share, at approximately 45%. The count of inpatient check-ups in the continent is growing, credited to the deep-rooted healthcare amenities, complete disease screening programs introduced by provincial, federal, and state governments, easy access to leading-edge technology, and rising requirements for improved management of the present diseases.

Additionally, the existence of the key players in the continent is a vital contributing factor to the market development.

Hence, the contrast media industry is growing because of the increasing volume of diagnostic imaging tests for all types of diseases, and is also projected to grow more in the future.

Read More

How Does Ultrasound Device Improve Healthcare?

The total size of the ultrasound devices market was at USD 6,929.7 million in 2021, and it will grow at a rate of 6.4% by the end of this decade, to reach USD 12,073.4 million by 2030.

Get the sample pages of this report: https://bit.ly/3FZyjlV

The medical device tech is transitioning in the direction of miniaturization, with transportable, lightweight devices substituting their bulky counterparts. For providing point-of-care treatment to patients, healthcare institutions are laying much emphasis on the employment of lightweight and compact devices.

Due to this, manufacturers in are introducing portable devices for facilitating improved healthcare.

Hence, the diminishment of ultrasound devices has brought about increased use in emergency and ICUs. 

Handheld devices come good for physicians in routine bedside scanning, which additionally decreases the overall cost and time related with healthcare. 

Used in deep therapy. So, compact/handheld portable ultrasound devices had a major share.

The ageing population necessitates wide-ranging care as it is susceptible to to illnesses as a result of its low levels of immunity, with the long recovery time additionally degrading its life quality. 

Diseases like diabetes and cardiac disorders are extremely prevalent in elder people as a result of their weak regenerative abilities, therefore leading to a surge in the requirement for improved diagnosis and therapy.

Ultrasonic imaging is a prevailing diagnostic tool for medical practitioners and researchers, and it is extensively acknowledged by reason of its non-invasive nature. Furthermore, the tech progressions in computing applications and transducers have transformed them and prolonged their application. 

Furthermore, device display is divided into B/W, color ultrasound of which the demand for color variants will grow with a rate of about 7% in the years to come.

In the recent past, the general imaging category dominated the ultrasound devices market with about 40%, as stated by a market research company, P&S Intelligence. 

This is as a result of the increasing obtainability of HIFU and the preference for them amongst physicians throughout tissue biopsy and the cancer treatment and  a number of other diseases.

Furthermore, end users demand for these kinds of devices is the highest amongst surgical centers, hospitals,  and diagnostics centers. This can be credited to the easy obtainability of sonography-based medical processes at these medical centers, development in in key regions, and increase in the usage of MIS diagnostic and surgical procedures here.

Europe had the most sales revenue, about 40%, in in the recent past. The development in focused ultrasound's clinical uses and the early commercialization of these devices, along with the considerable healthcare outlay across the advanced European nations, are helping the industry to grow.

It is because of the increasing elderly population across the world, the demand for ultrasound devices is on the rise, in the years to come.

Read More

North America Is Dominating Sleeping Aids Industry

The sleeping aids market is projected to be USD 157,484.5 million by 2030 growing at a CAGR of 7.3% during the forecast period, according to the estimates of the market research company, P&S Intelligence.

Get the sample pages of this report: https://bit.ly/42JtiHN

In 2021, North America held the largest revenue share approximately 50% in the market. This dominance can be credited to the rising frequency of sleep disorders and several initiatives by non-government and government organizations to spread awareness about the associated disorders and sleep hygiene.

The increasing acceptance of wearable monitoring devices and sensors is driving the market. Such devices support in transmission and record data related to several physiological conditions, for measuring and monitoring sleep quality. Some of the wearable sensors and monitors presented are BioHarness by BIOPAC Systems Inc., LifeVest by ZOLL Medical Corporation., LifeShirt by Aegis Limited, Zio XT by iRhythm Technologies Inc., and Sense Wear Armband by Jawbone.

In 2021, the Mattresses and pillows category had the highest revenue share, at approximately 40%. The availability of a wide range of international as well as local mattresses and pillows manufacturers makes these products cheaper which leads to their wide acceptance among people.

The Chinese market for products that support the sleep-deprived is rising at a high rate, mainly with youngsters looking to surge the quality and quantity of their sleep. 

Which indeed is contributing to the growth in the demand for obstructive sleep apnea machines, smart mattresses, and melatonin.

In China, with a growing amount of population suffering from sleep disorders, companies like Xilinmen and Xiaomi are spending more on scientific R&D to provide better products. Furthermore, key players are concentrating on exploring the potential effects of enhanced technology on sleep time.

Read More

Osteoporosis Can be Controlled with Osteoporosis Drugs

Medical science has evolved a great deal to say the least, and there are treatments and drugs for almost all the health conditions. Some conditions can be treated to the core and others can be prevented or slowed down. We will talk about the medications for osteoporosis in this blog.

The medications for osteoporosis help in improving bone density and preventing fractures. Some meds help build more bone, while others decrease the degeneration of bones.   

With age, bones become weak faster than the repairing capacity of the body. If a lot of bone density is lost, there is a chance that you might have developed osteoporosis.

Get the sample pages of this report: https://bit.ly/3FSyD5B

It is not possible to cure osteoporosis, but drugs can decrease the rate of degeneration or even stop it at the stage, where it is. Regular exercise, intake of calcium and vitamin D, can surely make a difference.

When the condition does not improve with exercise or intake of calcium, drugs might be prescribed. When we talk about osteoporosis drugs, there are numerous options available.

Which Drug Is Right?

The doctor will prescribe a drug on the basis of the severity of the condition of the patient. But that’s not the only thing to be taken into consideration. Here are some factors that will also be taken into account:

Sex- Some medicines are suitable for women, while others might be suitable for both the sexes.

Age- Age also plays a major role in deciding the prescription of drug for osteoporosis. Some are best for younger women who’ve already been through the period of menopause, others are suitable for older women.

Ease of Taking Medicine- The drugs are available in the form of pills to shots. Some have to be taken every day, and some only once a year. The right medication for you is the one that works best as per your condition.

Cost is a Crucial Factor- Shots or drugs taken through an IV calls for a visit to the doctor. This may cost more than pills that can be administered at home only.

Medical History- It is very important for a doctor to have a look at the medical history before suggesting a medication. If a patient is already suffering from kidney issues, breast cancer, or trouble with esophagus, some medicines can be more beneficial in that case than others.

What are Types of Osteoporosis Drugs

• Antiresorptive drugs help to slow down the rate that the bone is degenerated. They comprise denosumab, bisphosphonates, estrogens, calcitonin, and others. 

• Anabolic drugs come in handy for increasing bone formation. Some of the prime examples are teriparatide and romosozumab.

The drugs suggested, takes into account many things, such as whether they prevent or treat osteoporosis along with other medical conditions. Not all drugs are suitable for all people suffering from osteoporosis. For instance, a drug accepted to treating osteoporosis in women may not do the same in men. A specialist should be consulted to know that drug prescribed is perfectly suitable or not.

A lot of people in the world are suffering from osteoporosis and take drugs for the same, that is why the demand for the same is on the rise and will reach a value of USD 22,947 million by 2030.

Read More

How Is Improving Healthcare Infrastructure Aiding Respiratory Care Device Industry Growth?

A number of factors, such as the rising cases of respiratory illnesses, improving healthcare expenditure and infrastructure, surging pollution levels, growing urbanization rate, and rising aging population across the globe, are projected to boost the respiratory care device market. According to P&S Intelligence, the market is expected to reach $38,085.6 million by 2030. Moreover, the market is competitive in nature due to the surging number of local manufacturers.

To learn more about this report: https://bit.ly/3z8RSEn

Furthermore, the respiratory care device industry is witnessing a rising number of product innovations by respiratory care device companies. These players have been actively involved in the launch and development of new and advanced products, which are affordable, to meet the need of consumers. Some of the key companies operating in the market and offering new, advanced, and cost-effective devices are General Electric Company, Masimo Corporation, Medtronic plc, Hamilton Medical AG, ResMed Inc., and Koninklijke Philips N.V.

The primary factor driving the demand for respiratory care devices across the world is the surging healthcare expenditure in developed and developing countries. The governments of these nations are increasingly investing in the healthcare sector to improve the infrastructure and quality of healthcare facilities that are being provided to their residents. Due to this, the accessibility and affordability of the treatment and diagnosis of different medical illnesses, including respiratory diseases, are increasing.

The type segment of the respiratory care device market is categorized into therapeutic, diagnostic, and monitoring devices. Among these, the therapeutic devices category holds the largest market share, of more than 60%, and it is also projected to generate the highest revenue in the coming years, witnessing the fastest growth during the forecast period. This can be mainly attributed to the high demand for therapeutic devices from hospital and homecare facilities for the treatment of several respiratory diseases, such as bronchitis and upper respiratory infections.

Furthermore, on the basis of end user, the respiratory care device industry is classified into hospitals, emergency centers, homecare settings, and others. Among these, the hospital category accounted for the largest revenue share in the market. This was due to the fact that hospitals generated the highest demand for these devices across the world because most patients prefer them for treatment, as these places have the best equipment and trained staff across all medical specialties. On the other hand, the home care category is projected to witness the fastest growth during the forecast period. 

Geographically, North America is the largest market for respiratory care devices, with a more than 40% value share, and it is also expected to lead the global market throughout the forecast period. This is attributed to the growing geriatric population, high healthcare investments, improved healthcare infrastructure, and high incidence of respiratory diseases. In the regional market, the U.S. holds the leading position owing the rising number of people suffering from respiratory illnesses in the country, such as the COVID-19 infection presently.

Thus, the improving healthcare expenditure and infrastructure and surging number of product launches are expected to propel the growth of the market during the forecast period.

Read More

Diabetes on the Rise and So Is the Demand for Prefilled Syringes

Lifestyle diseases mainly occur due to long exposure to taking an unhealthy diet, smoking, and physical inactivity. It results in the development of chronic diseases, precisely stroke, heart disease, diabetes, metabolic syndrome, obesity, and some kinds of cancer. By the year 2030, the global deaths because of chronic diseases will increase to 70% and the global burden of disease to 56%. The utmost increase will be in the Eastern Mediterranean and African regions. Prefilled syringes do come in handy for the treatment of lifestyle and chronic diseases.

Increasing Diabetes Prevalence Driving Demand for Prefilled Syringes

It will not be a hyperbole to say that diabetes has become one of the most common medical conditions for people in the world. The instrument or syringe which is used to make a prick in the finger is a kind of prefilled syringe. The prefilled syringes industry will reach $3,646.7 million by 2030. The increasing cases of diabetes play a major role in uplifting the demand for these kinds of syringes.

Get the sample pages of this report: https://bit.ly/3lFxCY2

Demand for Pharmaceutical Products on the Rise

Vaccines and Therapeutic agents are some of the injectable products that experience an increase in demand, therefore leading to the development of prefilled syringes. As per the stats of the World Health Organization about 16 billion injections, which include 3% for immunization, 95% for remedial care, and 2% for preventatives and procedures of blood transfusion, are directed each year. The usage of these kinds of syringes has some benefits as compared to multi-dose vials, like a decrease in drug wastage and simple drug administration.

Customized Syringes are Trending

Injectable constructions are getting more complex, and there is a requirement for need strict quality control in order to meet the necessities of customers. Manufacturers are now focusing on the production and designing of prefilled syringes, which the people can use on their own without assistance from a medic. Therefore, the emphasis of producers is shifting on the way to self-administration dose syringes, as opposed to the ones used by healthcare providers, thus, it is becoming a positive trend for the high demand of customized versions of prefilled syringes.

Europe is Leading the Way

Europe is the region with the highest demand for prefilled syringes. The principal for this dominance of the region is the incidence of major prefilled syringe manufacturers, growing consciousness about safe injectable knowhow, high expenditure on healthcare, and increasing occurrence of long-lasting and lifestyle-related diseases. As per the, Our World in Data, cardiovascular illnesses, and cancer were the two foremost causes of death in the recent past.

The demand for prefilled syringes is on the rise mainly due to the rising cases of diabetes, increasing research and development, and funding for healthcare.

Read More

How Does Healthcare Sector Benefit from Label-Free Detection Technology?

Label-free detection technology utilizes optics-based biosensors for the conversion of biological binding responses into signals without requiring fluorescent or any other label. It allows for the real-time monitoring of the changes that happen during analyte binding to an immobilized ligand on a biosensor surface, without individual assay components’ manipulation. The major benefit of the label-free technology is that it enables ligands to maintain their original conformation and biological activity.

This technology also mitigates the risk of the unwanted background signal that may be caused while binding labels non-specifically to other bioassay components, by eliminating labeled detection reagents’, such as fluorescently-labeled proteins and enzyme-conjugated antibodies, requirement. It is also advantageous while working with impure or complex sample material containing various components other than the analyte of interest.

Moreover, it facilitates researchers while performing analyses that are not possible with the conventional methods. Label-free monitoring enables affinity and kinetic analysis, including binding specificity evaluation, which are essentially aided by dynamic, real-time interaction analysis.

Get the sample pages of this report: https://bit.ly/40PuO9J

Surface Plasmon Resonance

Surface plasmon resonance (SPR) is an optical technique for carrying out label-free detection. It provides accurate results without any chance of the normal functioning of the ligand or analyte being affected upon binding with the labels. It also saves cost, as it does not involve the use of expensive radioactive fluorescent labels and other reagents. In addition, SPR facilitates the detection of the changes in the dissolved material’s mass in the solvent layer close to the surface of the sensor, by measuring the change in SPR angle or refractive index.

Binding Kinetics 

Kinetic binding refers to the phenomena of how quickly a compound binds to its target and how quickly it disassociates. It primarily measures the on-rate and off-rate.

Application of Kinetic Binding in Drug Discovery

The drug-induced conformational changes and binding kinetics to physiological target determine how a dose-response relationship is influenced by coupling efficiency. Binding kinetics provides support in evaluating the affinity of a drug to its target, and it can also affect the efficiency of the drug-response relationship by impacting the equilibrium state, thus resulting in improved efficacy with a longer duration of the response and differentiation of the therapeutic indications, along with higher tolerability.

Moreover, in the series of typical and atypical antipsychotic drugs, the measurements of the kinetic binding properties, along with correlation of the side effects, birthed a new model of binding that reflects that association rates are primarily responsible for causing side-effects, not the dissociation rates. It creates opportunities to build strategies to optimize kinetics at the D2 receptor and enhance the therapeutic profile of atypical antipsychotic drugs.

Therefore, the demand for label-free detection technology is rising due to the high efficiency and accurate results it provides without variations, as compared to conventional label-based technologies.

Read More

North America Is Dominating the Wound Dressing Industry

The size of the wound dressing market was USD 10,427.0 million in 2022, and the figure is set to rise at a CAGR of 6.1% in the duration of 2021–2030 and reach USD 16,751.6 million by the end of this decade, as per P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3FRRMon

The growing elderly populace plays a vital role in the advancement of the industry. As per the United Nations Department of Economic and Social Affairs report on global Populace Aging, the percentage of the public aged 60 years and above is rising at a significant rate.

The number of persons aged 60 years and above amplified from 382 million in 1980 to 1 billion in 2019 and is projected to touch approximately 2.1 billion by 2050. Developing countries, including India and China, consists the highest number of elderly people than developed countries, such as Germany, the U.K. France, and the U.S.

The aged populace requires extensive care, as they are more prone to sicknesses due to a high recovery timespan and low immunity. Elderly people have weak body functions resulting in a long time to heal, compared to adults. The reduced blood circulation and reduced collagen deposition result in delayed healing in aging people.

The demand for these dressing items is growing because of the increasing frequency of chronic and lifestyle-associated illnesses, which contributes to a surge in the number of operations, worldwide. The occurrence of chronic diseases, including cancer, heart disease, and respiratory illness is growing because of alterations in lifestyle and lack of preventive care.

Burns are caused by several reasons, including friction, chemicals, electricity, radiation, and heat. They can cause loss of tissue, skin, and blood vessels.

In 2022, North America had the largest wound dressing market share, approximately 45%. The industry is developing because of the fast growth of the elderly population, snowballing number of burn cases and road accidents, and increasing frequency of chronic wounds.

Furthermore, the growing number of burn incidences and road accidents have also amplified the need for several kinds of wound care items like dressings in North America. For example, as per the National Highway Traffic Safety Administration, 42,915 lives were lost because of road accidents in the U.S., in 2021. Moreover, the growing frequency of burn cases and road accidents needs traditional and enhanced dressing items for their treatment.

The growing obese populace is also contributing to advancing the demand for such items in the continent. The obese public is at a high risk of pressure ulcers, which can ultimately lead to an increase in the probability of infections. Fat deposition around the edges of the wounded part stops skin closure and increased healing time. With the surge in the cases of geriatric population, road accidents and elderly population the U.S. had approximately 90% in 2022 of the revenue.

Hence, the surge in geriatric population, road accidents, and increasing burn cases will drive wound dressing in the future as well.

Read More

Overview of Pharmacovigilance: Importance and Types of Methods

Vaccinations and medications have revolutionized the prevention and treatment of illnesses. Medicinal medicines may have effects in addition to their advantages, some of which could be unwelcome and unexpected.

Pharmacovigilance is the study and practice concerned with identifying, evaluating, comprehending, and avoiding side effects or any other issue with drugs or vaccines. Before being approved for use, all medications and vaccines undergo extensive clinical studies to assess their safety and efficacy.

Therefore, the clinical trial procedure entails observing these goods briefly in a few carefully chosen people. Only when these drugs have been used by a diverse population, including those with other concomitant ailments, may some adverse effects become apparent for an extended time.

The Importance of Pharmacovigilance

Pharmacovigilance is crucial because it establishes rules for businesses that produce medications. These rules emphasize both the safety of the medicine and its potential benefits. By 2030, the pharmacovigilance industry will be worth $15,259.8 million.

Get the sample pages of this report: https://bit.ly/42zz0Mj

The prevalence of toxicity and adverse drug reactions (ADRs), growing worries about drug safety, and high patient compliance with medication use are all critical contributors to this rise. There are four sub-specializations within the vast field of pharmacovigilance. As follows:

• Operations

Life science graduates typically begin their careers in the industry in the operations sector. Drug safety officer/associate, Case processor, manager, and team lead are among the job descriptions. These people gather and keep track of data throughout pre-clinical research and clinical trials. Additionally, they compile data on unfavorable incidents that patients and medical personnel have reported.

• Surveillance

Most of the positions in this area are in signal detection and risk management. These specialists analyze the data that various other sectors have gathered. They also assist with the preparation and evaluation of aggregate reports.

• Systems

This industry is charged with developing a reliable and cutting-edge system. They are primarily in charge of facilitating access to vast safety data. Professionals in operationally oriented positions collect this data.

Licensed Individuals in Pharmacovigilance

These job descriptions are the only ones that concentrate on commercially available medications that require their approval; however, due to the strong demand for their knowledge throughout the field. Senior professionals are the only ones with this profile, advising businesses on the EU legislation that must be adhered to.

What Are the Pharmacovigilance Methods?

There are several crucial techniques used in pharmacovigilance, including

• Spontaneous Reporting

Due to the widespread usage of the spontaneous reporting approach in identifying major, novel, and uncommon ADRs, attributed to its efficacy and cost-effectiveness, it commands the most significant share in the pharmacovigilance market. Additionally, regulatory agencies and the pharmaceutical business commonly employ the reports produced using this procedure.

• Cohort Event Monitoring

In this approach, the monitoring study is prepared before the drug therapy even starts. A group of individuals is exposed to medication for a certain amount of time and is closely monitored throughout treatment. Monitoring is done for adverse drug interactions or those connected to one or more medications taken along with the target drug.

Read More

Does Human Growth Hormone Slow Aging?

Growth hormone increases childhood growth and helps in maintaining tissues and organs throughout life. It's formed by the pituitary gland, which is located at the base of the brain. Commencing middle age, though, the pituitary gland gradually decreases the amount of growth hormone.

This usual slowdown has caused an interest in the use of synthetic HGH as a way to fend off some of the changes associated with aging like a decreased mass of bone and muscle.

There's little evidence suggesting that HGH can help healthy adults recuperate youth and vitality. On the other hand, Human growth hormone treatments might surge the risk of other medical conditions. Experts endorse the use of HGH to treat aging or hormonal conditions.

To learn more about this report: https://bit.ly/40osjus

Do some adults require HGH treatment?

Adults with a growth hormone deficiency, not the likely decrease in growth hormone because of aging, might be given synthetic HGH by the medics.

The deficiency of growth hormone is generally caused by a benign tumor on the pituitary gland or by treating an adenoma with the help of surgery or radiotherapy.

For adults having an HGH deficiency, injections can:

• Increase the capacity to exercise

• Increases the density of bones 

• Increase the mass of muscles

• Decrease fat in the body

HGH treatment can also treat adults with AIDS- or HIV-associated growth hormone deficiency causing the irregular distribution of body fat.

Effect of Treatment on healthy older adults?

The cases of healthy adults consuming HGH are limited and inconsistent. Even though it appears that HGH can surge muscle mass and lessen the body fat in healthy older adults, the surge in muscle doesn't translate into improved strength. It isn't clear if HGH offers other aids to healthy adults.

Potential risks of HGH treatment

HGH treatment may cause numerous side effects for healthy adults, including:

• Increased insulin resistance

• Carpal tunnel syndrome

• Type 2 diabetes

• Swelling in the arms and legs 

• Joint and muscle pain

• For men, enlargement of breast tissue (gynecomastia)

• Augmented risk of some cancers

Studies of HGH treatment in healthy adults have been comparatively small and short in period, so there's little to no info pertaining the lasting effects of HGH treatment.

Does HGH come in pill form?

HGH treatment is agreed in only the U.S. for treatment of growth hormone deficiency, and problems related to HIV infection. HGH is only useful if directed as an injection.

There's no pill available for HGH. Some nutritional supplements that claim to lift the levels of HGH come in pill form, but there are no such benefits as per the studies.

HGH is considered a controlled substance by the Food and Drug Administration. The use of HGH for an unapproved condition like building muscle or as an anti-aging treatment in adults is considered as illegal.

The Bottom Line

If you have precise concerns pertaining to aging, you can always consult your health care provider about confirmed ways to advance your health. Keep in mind, that healthy lifestyle choices, like eating a healthy diet and physical activity can help you feel good even at a growing age. Whatever may be the case, there is an increase in the demand for HGH, and will reach a value of above 14,498 million by 2030.

Read More

Hospital Beds: Types and Importance

A bed is more than just an area to sleep in at a hospital. This is a piece of medical gear that has been carefully selected to fit the patient's unique demands. The ability to position patients on hospital beds for optimum comfort and recovery makes them vital.

Additionally, a variety of hospital beds with cutting-edge features are offered on the marketplace, including beds with hydraulic adjustment and beds powered by alternating current (AC) to change the surface and height level of the bed. These factors will cause the hospital bed market to reach $8,276.7 million in 2030.

To learn more about this report: https://bit.ly/40xSeQJ

Why Do Hospital Beds Matter So Much?

Hospital beds are crucial for a variety of reasons. Patients may relax and recover in a welcoming and secure environment thanks to them. Additionally, hospital beds make it simple to reach medical personnel and equipment. 

In an emergency, this may be very important. Additionally, hospital beds may be altered to accommodate certain patients' needs, which is crucial for people with mobility concerns.

Due to the patient's comfort and convenience of changing positions, a hospital bed with an electric motor is a great option. One of a hospital bed's most crucial components, safety rails are meant to lessen the likelihood of the most frequent accidents.

Everyone concerned will heal much more easily and quickly if the proper hospital bed is used. By using an automatic hospital bed, the patient is protected from the discomforts associated with sitting in a wheelchair as well as the signs of spine misalignment.

Improvements in Hospital Bed Technology

A number of technical developments, like the availability of autonomous beds and hospital beds with IoT capabilities, are promoting the expansion of the hospital bed sector. 

Hospital beds equipped with power mattresses, which aid in pressure redistribution and enhance blood circulation in bedridden patients, have also been developed by major corporations.

Moreover, old beds are also being replaced by beds with new & advanced features, such as graphical interfaces, novel environment-aware sensors, and actuating solutions.

Types of Hospital Bed 

Patients may customize any modern hospital bed to suit their changing demands since they are all adaptable. What powers the various kinds of hospital beds is what distinguishes them. Hospital beds come in three different varieties: semi-electric, manual, and completely electric.

Manual: The height of these beds may be changed, and the foot and head of the bed can be raised and lowered using hand cranks. The capacity to use this type of bed and, consequently, the patient's comfort and freedom, should be physically possible for the patient or caregiver.  

Semi-Electric: The bed's head and foot rails are lowered and raised by an electric motor. The patient physically turns a hand crank to change the height of the bed.

Fully Electric: With the use of a pendant or remote, the patient may adjust the position and height of the bed. The bed may be raised to a suitable height without the need for a hand crank, making it simpler to get in and out of bed and for the caregiver to tend to the sufferer or change their bedding.

Read More

North America Leads the Way for ENT Devices Industry

The ENT devices market was valued $17,440 million in 2021, and will reach $31,805 million by 2030, at a growth rate of 7% in the years to come. The thriving incidence of hearing ailments and sinusitis, increasing preference for MIS procedures in ENT specialty, and growing healthcare outlay are boosting the industry.

To learn more about this report: https://bit.ly/42A58iL

Diagnostic devices had the largest share, of above 44%. This is because of the obtainability of numerous products, entrance of new players, rise in the ageing population, and surge in the occurrence of numerous ENT ailments. Furthermore, the new product launch will propel the industrial growth.

Hearing aids follow diagnostic devices. This is since manufacturers are further focused on introducing advanced hearing aids to consolidate their presence in the market. 

North America was the regional leader with around 33%, in the past. This has a lot to do with to the improving recompence scenario for ENT processes and the existence of the market stalwarts’ players in North America. Furthermore, the increasing consciousness about the benefits of ENT devices is a reason for the increased acceptance of these devices.

APAC will have the highest growth rate in the years to come, where the Peoples Republic and India are the main regional markets. The main driving forces are the existence of a high patient pool who have sinusitis, the surge in consciousness about these devices, and the increase in the ageing population in the region.

The increasing elderly population and the increasing incidence of hearing ailments will help the demand for ENT devices to boom further in the years to come.

Read More

Portable Ultrasound Devices Ruling the Roost, Why Is It So?

Before we understand about the portable version of ultrasound, let’s take a dive into the concept of ultrasound machines. Most of you must be familiar about what are ultrasound devices but let us discuss about them here in detail, for making the understanding clearer. When doctors or medical experts want to have a better look at what’s going on inside the patient’s body, they often use them for getting diagnostic imaging.

This imaging is done with the help of an ultrasound device. An ultrasound machine is also known as an ultrasonography machine, which takes pictures of internal organs from the topmost layer of the skin without any insertion with the help of high-frequency sound waves.  

A gel is applied on the skin in order to get the ultrasound waves transmitted from the transducer through the gel into the body. These images or scans are reflected on an attached computer screen. 

These images are used by medical experts for diagnosing problems with any tissue or the organ of the body. Ultrasounds are mostly performed for heart, stomach, liver, kidneys, uterus, unborn foetus, pancreas, etc. These images help the medical experts to understand the condition of any tissue or organ and make a more accurate diagnosis, on the basis of the same.

Portable Ultrasound Devices

As the name suggests, a portable ultrasound machine is a portable or smaller version of an ultrasound machine that almost has the same functions as the conventional device. However, these machines are not able to produce detailed imaging as the conventional counterpart, but they help in instant diagnosis. These mobile ultrasound systems could be carried here and there and work on batteries as well. 

Get the sample pages of this report: https://bit.ly/3n6qS5Q

Benefits of Portable Ultrasound Devices

Instant Diagnoses: Portable ultrasound devices give accurate and instant diagnoses as they can be done at the bedside of the patient. Full-size ultrasound machines are not that easy to be moved or transported. On the other hand, portable ultrasounds can be moved from one place to other.

Affordability: Conventional ultrasound devices are bulky and expensive. Whereas, portable devices are not just handy but also affordable. This helps hospitals provide individual device to the doctors and other medical practitioners.

Emergency Usage: The queue in front of the ultrasound room could be life threatening in some cases, when the patient is critical. Portable ultrasound machines eliminate the transporting challenge for emergency patients by providing imaging at the patient’s location.

Why ultrasound is preferred over other types of imaging

No Ionizing Radiation: One of the foremost benefits of ultrasound imaging are that it works on ultrasonic sound waves for developing images. Ultrasound techniques do not use radiation. So, there are almost no adverse patient responses as opposed to radiation exposure.

Non-Invasive Procedure- Another major benefit of ultrasound is that it does not require invasive procedures. 

Ultrasound imaging makes use of high-frequency sound waves to produce images of the internals of the body. With no first-hand risks, the portable ultrasound devices not just benefit the patients but also the doctors. Owing to all these benefits associated with portable ultrasound devices, the demand for the same will reach to a value of above $3,488 million by 2030.

Read More

Why Is Patient Handling Equipment Becoming More Common?

Pushing, lifting, holding, lowering, or tugging patients is referred to as "patient handling." Patient handling equipment is a specialized disability, mobility, and rehabilitation gear created to meet the various healthcare requirements of hospitalized patients while also ensuring their convenience and quality of sleep.

Equipment for safely transporting or assisting a patient or any bodily parts is known as patient handling equipment. By lowering the danger of biomechanical overload and work-related injuries and requiring a high level of care and competence, the equipment enhances the working conditions for care. Additionally, the equipment enhances the standard of medical care and considers patient safety.

Get the sample pages of this report: https://bit.ly/40hWt2s

The Prevalence of Disabilities Is Rising

Patient handling equipment is spreading more widely as the global number of people with disabilities grows. In 2019, the WHO estimated that 15% of the global population is disabled, with 2% to 4% of that population experiencing functional issues.

The fast development of chronic diseases contributes to an increased population of disabled persons. Patient handling equipment is necessary for disabled persons to do their everyday responsibilities. Due to an increase in the prevalence of disabilities, the patient handling equipment industry is predicted to grow rapidly.

Increasing Numbers of Elderly and Obese People

Because life expectancy has grown over time, there are steadily more people in their 60s and beyond. As per the UN Database on World Population Ageing 2020, there will be 1.5 billion older people worldwide by 2050, up from 727 million in 2020.

Older people are more likely to have fall-related injuries, which can lead to a range of functional restrictions and a need for mobility aids. As a result, it is anticipated that the global elderly population will grow dramatically, driving the need for patient mobility and handling equipment.

Increasing Need for Healthcare Services

Additionally, the patient handling equipment market would benefit from the growing need for healthcare services. Around the world, more and more regulations are being passed by governments to shorten and reduce the cost of medical treatments.

The need for equipment utilized to assist patients in such settings, including mobility devices, patient transfer devices, and medical beds, will increase in the coming years as the need for home care rises.

North America Uses Most Patient Handling Equipment

Meanwhile, it's anticipated that North American healthcare professionals will start investing in more sophisticated equipment. The industry share for innovative technologies will rise further as demand for more intricate machinery rises.

Worldwide sales of hospital beds and patient transport equipment are increasing quickly for wounded senior people. The industry's growth is being fueled partly by specialty beds for long-term care, psychiatric treatment, and curative care.

The Bottom Line

Smart technology will tend to set the pace for patient handling equipment, regardless of the devices created. As more licensed items enter an industry pushed by the needs of an older population familiar with technological equipment, medical institutions should anticipate a rise in patient demand for better care and alternatives and available treatments.

Read More

Lung Cancer Surgery Industry To Observe Fastest Growth in Asia-Pacific

The lung cancer surgery market was USD 5.65 billion in 2022, and it is likely to propel at a rate of 4.10% from 2022–2030, to reach USD 7.79 billion by 2030, as per a report by P&S Intelligence. The rising incidence of lung cancers, increasing tobacco smoking by younger generation, growing elderly population, and reimbursement availability are driving the growth of the industry.

Get the sample pages of this report: https://bit.ly/3FDv1nX

Due to the trend of smoking at every age group, the cases of lung cancer are increasing significantly, and it is among the most-common reasons for cancer death among the population. 

Lung cancer is the most-common malignancy worldwide, with an age standardized rate of 22.4 per 100,000 person-years, as per the GLOBOCAN. This condition is more prevalent in men. In the year 2020, the incidence rate in men was 222 and 186 in women. Thus, the rising demand for surgeries is the reason for the industry growth.

North America is the leader of the industry because of the rapid technological developments in the oncology space, growing trend of smoking tobacco, and increasing incidence of lung cancer. According to the Lung Cancer Research Foundation, around 236,740 people suffered from lung cancer and 130,180 died in 2022 in the U.S.

APAC will have the fastest growth in the near future because of the rapid healthcare infrastructure development, increasing funding by government and initiatives for raising awareness, and growing medical tourism industry in India and China.

Hence, with the rising elderly population and the rising number of awareness campaigns, the demand for  lung cancer surgeries will grow considerably in the years to come. 

Read More

Rise in Cases of Cancer Boost Sale of Single-Cell Analysis

Biomedicine and cell biology both use single-cell analysis as a crucial tool. Modern, superior optical technology provides the foundation for the creation and advancement of single-cell analysis. To date, a wide range of optical detection techniques, including super-resolution optical microscopy, optical tweezing, fluorescence imaging, dynamic light scattering, hyperspectral microscopy, and evanescent-wave sensing, have been utilized for single-cell analysis.

Single-cell genomics research of diseases allows for the development of individualized medical therapies that are personalized to each patient's unique requirements and features. Single-cell analysis methods have evolved, providing individualized therapy for uncommon illnesses possible. The worldwide single-cell analysis industry will grow at a considerable CAGR in the next years as a result of personalized medicine's ability to monitor and treat patients in line with their unique demands.

Get the sample pages of this report: https://bit.ly/3JRChPC

Single-cell analysis is an effective technique used to study biological heterogeneity deeply and influence therapy choices. Lung cancer, breast cancer, brain cancer, bladder cancer, colon cancer, acute myeloid leukemia, and melanoma have all benefited from its use. Numerous fields, including immunology, prenatal diagnostics, neuroscience, embryogenesis, plant biology, and microbiology, use single-cell analysis extensively.

Companies interested in investing in the single-cell analysis market have potential due to the promising stem cell research environment, expanding healthcare sector in emerging nations, and integration of microfluids. Investments in the medical field of developing nations, like India and China, offer greater potential than investments in industrialized nations due to their rising healthcare infrastructure and huge populations.

Techniques Available for Identifying Single Cells Their Advantages?

Currently, single-cell imagers, flow cytometry, and single-cell sequencing are the three methods used for single-cell analysis.

• Single-Cell Imagers

Typically, they can single cells or groups of cells to detect the presence of particular proteins or cell characteristics using fluorescent or colorimetric probes. Moreover, they are useful for identifying phenotypes.

• Single-Cell Sequencing

Following bioinformatic analysis, single-cell sequencing produces data-rich results that give a deep understanding of the variability of gene expression throughout a population. Only with a few 100 cells being studied in every experiment, the throughput is quite poor. But, when combined with microfluidics, this can vastly improve.

• Flow Cytometry

A well-known technique with astoundingly high throughput, flow cytometry measures about 70,000 events each second. Some assay capabilities are available.

In the single-cell analysis market, end customers include biotechnology firms, medical facilities, cell banks, IVF clinics, as well as research organizations. The hospital category holds the largest market share, and it is expected that it will continue to advance at a fast pace in the coming years. This is because hospitals offer their patients high-quality diagnostic services and a secure atmosphere.

Hence, demand for single-cell analysis will rise rapidly in years to come. This can be attributed to the rising prevalence of cancer and growing healthcare sectors in developing nations.

Read More

Rising Prevalence of Chronic Health Disorders Drive Chronic Pain Treatment Industry

Over 60% of people in the world will increase from 12% to 22% between 2015 and 2050, as per the WHO. Moreover, a major issue for care facilities is the high prevalence of chronic pain among older residents in nursing homes.

Pharmacological, non-pharmacological (physical therapy, such as exercise, foot orthotics, or patellar taping for knee osteoarthritis) and occupational therapies (assistive devices and joint protection education) are the main treatments used to treat this condition in the elderly population, which in turn has a positive impact on the need for chronic pain treatment.  

The main growth factors for the worldwide chronic pain treatment market are the growing geriatric population, rising elderly population, and rising prevalence of chronic health disorders. The sector will generate USD 162,175.2 million in sales in 2030 as a result of the aforementioned causes, as per P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3LAuXJq

One of the biggest healthcare burdens on the planet, which affects both high-income and low- and middle-income countries, is the increased prevalence of chronic diseases. Moreover, osteoarthritis, fibromyalgia, cancer, sickle-cell anemia, and autoimmune disorders (rheumatoid arthritis) are a few examples of chronic diseases that call for therapeutic intervention for effective pain management.

Cancer Pain Categories Will See Rapid Growth

According to predictions, the category of cancer pain will rise the fastest in the future. Cancer is one of the top causes of death worldwide, according to the NCI.

By 2040, it is anticipated that there would be 29.5 million new instances of cancer diagnosed annually, with 16.4 million cancer-related deaths. As a result, the market is being driven by the growing number of cancer survivors because the condition results in severe, prolonged pain.

The hospitals category will achieve the highest growth rate in the years to come. Hospitals are the places where pain management procedures are used most frequently, especially for post-surgical pain, where the high cost of monitoring and treating side effects results in the need for pain management treatment and medications.

North America Led Market Demand

Geographically, North America was the highest revenue generator in the chronic pain treatment market in 2020 due to the high healthcare spending, developed healthcare infrastructure, and widespread accessibility to cutting-edge medications and medical equipment.

On the other hand, the APAC market is anticipated to experience the quickest growth during the forecast period, largely due to the region's expanding elderly population, improved healthcare infrastructure, rising per capita income, and surging cases of chronic pain. 

Drugs Categories Dominate Industry

The market for treating chronic pain was dominated by the medication category. This is partly because several chronic pain conditions, such as excruciating headaches or migraine pain, lower back pain, and facial discomfort, are becoming more common. 

Additionally, the market for painkiller medications will grow due to the increasing senior population worldwide, sedentary lifestyle, and increase in surgical operations. 

According to the application, the musculoskeletal category accounted for the largest share of the market for treating chronic pain. The high prevalence of musculoskeletal conditions including fibromyalgia, osteoarthritis, and rheumatoid arthritis is mostly to blame for this.

Read More

Hospitals Dominated Nuclear Imaging Equipment Industry

As per a report by P&S Intelligence, the size of the nuclear imaging equipment market was USD 2,651.3 million in 2021, and it will grow at a rate of 6% in the years to come, for reaching USD 4,463.7 million by 2030.

The acceptance of hybrid PET/CT medical methods has brought about a strong interest in hybrid PET/MRI and SPECT/CT systems additionally. The SPECT technology had a over 50% share in the past. As opposed to standalone devices, hybrid equipment provides more-precise images, with a higher resolution. In a single inspection, these devices can bid both physiological and morphological data.

To learn more about this report: https://bit.ly/3ZTlqSk

For example, the SPECT/CT system allows specific localization and improved specificity of the data delivered by a CT scan, in the case of skeletal inspection. Numerous hospitals are progressively switching from standalone to hybrid equipment because of these advantages.

Some of the current progressions in imaging technology that are applicable to radionuclide therapy include:

A main benefit of PET/MRI over PET/CT is an improved soft tissue contrast, which is essential for treatment planning, dosimetry, and post-radionuclide therapy assessment. It is beneficial since it offers the concurrent co-registration of MR descriptions, which is significant for precise dosimetry.

Based on users, hospitals had the largest share, about 60%, in the recent past in the nuclear imaging market. This has a lot to do with the high incidence of lingering ailments, growing public consciousness of nuclear therapy, and the transition from solo to hybrid modalities.

Also, numerous nations, chiefly the U.S. and those in Europe, are making a eagerness assessment framework for effective and smart ways of putting to use radio drugs, so as to offer safe and effective treatments. Therefore, most hospitals are concentrating on the therapy for cancer patients, encouraged by its high efficiency and few side-effects. Nuclear imaging is by now making a main contribution in detecting the area of spread of the cancer in the body.

Additionally, the hospitals will grow at a considerable rate, about 7%, in the years to come, because of the increasing investment in nuclear imaging equipment research and development, increasing count of diagnostic institutes, and a high volume of nuclear tomography procedures.

It is possible with data-integrated imaging systems make to process and recreate images, recognize medical subjects with the support of a computer, generate 3D digital representations of the composition, and employ proper quality control measures. 

Doctors can rapidly compare scans to precisely track the ailment's course, with the usage of integration of data. Clinicians now wish easy access to comprehensive data on patient diagnostic history, for developing a treatment plan that would be fruitful along with being cost-effective.

It is because of the increasing aging population, the demand for nuclear imaging equipment will be om the rise in the future.

Read More

Rising Prevalence of Chronic Diseases Boost Demand for Wearable Injectors

The wearable injectors industry contributes $6.95 billion in 2021, and it is projected to advance at a rate of 12.6% from 2021 to 2030, to generate $20.21 billion in 2030. It is ascribed to rising health hazard concerns, led by conventional injectors, coupled with growing demand for conventional and novel drug molecules.

In addition, the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases, and favorable reimbursement policies are projected to boost the demand for wearable injectors in the coming years.

To learn more about this report: https://bit.ly/3JKeXmS

Infusion therapy costs around $35 billion in the specialty drug industry. The subcutaneous injection is the most popular administration route in various therapeutic areas, including hemophilia, cancer, autoimmune disorders, and multiple sclerosis. It accounts for 50% of the expenditure on specialty medicine in the U.S.

The single-dose administration through IV infusion in the clinic or hospital costs around $1,000 to $10,000, while the homecare administration of the same dose costs 30% to 70% lesser.

The home usage of advanced medicine delivery devices, more specifically wearable injectors results in overall cost reduction, with an infusion of the medication by themselves, with no or minimal training.

In addition, these devices are economic compared to other controlled-delivery devices, as they are widely preferred options in laboratories, diagnostic centers, and clinics.

Moreover, the cheaper prices of these devices, compared to other controlled-delivery devices, resulted in their wide popularity in laboratories, clinics, and diagnostic centers.

Furthermore, biological drugs are large molecules, and more viscous compared to other drugs. They cause lesser pain during injection. The usage of the biological molecules with pharmacokinetics and subcutaneous back pressure boosts the usage of the biological molecules.

The slow administration of the drug is required for reducing patient discomfort and improving the drug's performance. For example, immunoglobulins are used for administering large volumes, and therefore, the preferred method is subcutaneous delivery. Immunoglobulins are administered in a specialized clinic or in a hospital through insertion sets or syringe pumps.

Wearable injectors are massively used compared to conventional drug delivery approaches, as they work efficiently in drug administration, at a controlled rate.

Presently, four subcutaneous immunoglobulins are commercially used in the U.S., with a tolerance flow rate ranging from 20 mL/h to 30 mL/h per site. There are various pipeline biological drugs in the R&D phase, with wide usage of oncology in the treatment, followed by autoimmune disorders and infectious diseases.

Wearable injectors provide support in reducing the overall healthcare cost, including drug administration and improvement in patients’ lives, thus fuelling the industry's growth.

The major players operating in the industry are; Medtronic plc, SteadyMed Ltd., Ypsomed Group, Unilife Corporation, Insulet Corporation, F.Hoffmann-La Roche Ltd., Johnson & Johnson, Becton, Dickinson, and Company, and West Pharmaceutical Services Inc.

Therefore, the rising demand for wearable injectors is led by the growing prevalence of chronic diseases.

Read More

North American Medical Equipment Maintenance Industry To Prosper in Coming Years

From $17.4 billion in 2019, the global medical equipment maintenance market revenue is predicted to surge to $45.1 billion by 2030. According to the estimates of the market research company, P&S Intelligence, the market will demonstrate a CAGR of 9.4% from 2020 to 2030 (forecast period). The market is being driven by the rapid advancements being made in medical devices, enactment of strict regulations, and growing public awareness about preventive maintenance all over the world. 

Get the sample pages of this report: https://bit.ly/3lp598z

The expansion of the medical device industry is propelling the growth of the medical equipment maintenance market. In recent times, the healthcare sector has witnessed several rapid advancements, especially in diagnostic equipment. Moreover, the players operating in the industry are actively focusing on manufacturing high-quality diversified products with the help of advanced technologies and exhaustive research and development (R&D) activities. These devices have a certain lifespan and need replacement or maintenance after a certain period of time. 

Besides, the growing public awareness about the significance of preventive medical equipment maintenance is also driving the expansion of the medical equipment maintenance market. For example, the World Health Organization has laid down guidelines for infection control and hospital hygiene, which focus heavily on equipment maintenance. Due to this factor, many healthcare providers are actively incorporating maintenance services for several devices. For example, Montana State Hospital implemented a preventive maintenance program in August 2017 for increasing the useful life of equipment and building and ensuring the safety of patients and personnel. 

Depending on equipment type, the market is divided into electromedical, surgical, life support, dental, and imaging categories. Out of these, the imaging equipment category dominated the market in 2019. This was because of the fact that this device is heavily used for the diagnosis of several medical conditions, such as neurological issues, heart diseases, and tumors. When service provider is taken into consideration, the market is classified into independent service organizations (ISOs), in-house, and original equipment manufacturers.

Amongst these, the ISO category is predicted to register the fastest growth in the market in the coming years. This is credited to the high cost of the services provided by OEMs, which is subsequently propelling the popularity of ISOs. Across the globe, North America contributed the highest revenue to the medical equipment maintenance market in the past, and this trend is predicted to continue in the coming years as well. This is attributed to the mushrooming population of geriatric people, increasing number of hospitals, rising prevalence of diseases, and surging use of medical imaging systems in the region. As per the data released by the American Hospital Association in January 2019, in 2017, the total number of registered hospitals in the U.S. was 6,210.

Hence, it can be safely said that the demand for medical equipment maintenance services will surge sharply in the coming years, mainly because of the growing incidence of diseases and rising public awareness about hygiene all over the world.

Read More

Spectroscopy Technique Led Process Analytical Technology Industry

The term "process analytical technology" (PAT) refers to a system for the analysis and control of production processes that measures essential quality criteria and performance characteristics of raw and in-process materials. It makes it possible to use in-process data to evaluate a batch's quality during manufacturing, greatly lowering the requirement for final product testing, and thus shortening lead times.

Moreover, PAT has been crucial to the pharmaceutical industry's process development and scale-up of asymmetric chiral compound syntheses, including active pharmaceutical ingredients. Thus, the process analytical technology market is expected to hit USD 13,626.5 million by 2030, as per P&S Intelligence.

Further, the PAT's key advantage is that quality is integrated into the final output rather than being checked before it is released. It aids in reducing batch rejection, shortening manufacturing cycle times, and boosting automation.

To learn more about this report: https://bit.ly/3lcizEZ

Rising Importance of PAT in Pharmaceutical Industry

The pharmaceutical manufacturers category holds the largest share, of 67%, in the market. This is due to the growing importance of PAT in the pharmaceutical industry's process development and scaling-up of asymmetric syntheses of chiral compounds, including active medicinal components.

Moreover, the category of biopharmaceutical manufacturers is predicted to register the fastest growth rate. This is a result of the growing biotechnology sector and increasing requirement for biochemical analysis brought on by the acceptance and introduction of several biologic medications.

A Sample Can Be Examined at Various Stages Using Spectroscopy

In 2022, the spectroscopy technique accounted for the largest share, 52.2%, in the market, and this category is predicted to maintain the fastest rate in the years to come. This is explained by the rise in pharmaceutical and biopharmaceutical R&D efforts and the accompanying process optimization in technology.

In addition, spectroscopy aids in determining a sample's atomic structure and the molecular structure of the muscle, monitoring the concentration of dissolved oxygen in freshwater and marine environments, researching the emission lines of distant galaxies, modifying the structure of drugs to increase their space exploration, identifying proteins, efficiency, and respiratory gas analysis in hospitals.

The most popular spectroscopic method has also been molecular spectroscopy. Due to its extensive applications and rising demand in the pharmaceutical and biopharmaceutical sectors, the category is predicted to enjoy significant expansion in the future years.

Rising Government Investment in Biotechnology and Pharmaceutical Sectors in Asia-Pacific

Geographically, APAC will grow at a 19.6% CAGR in the coming years attributed to the existence of several USFDA-approved pharmaceutical businesses, burgeoning biotechnology sector and expanding usage of analytical technologies, high R&D spending, increase in the frequency of various diseases that results in the rise in consumption of biologic and pharmaceutical medications and increase in healthcare spending.

Moreover, the European region is set to advance at an 18.2% rate in the future years. Despite maturing, the region's need for PAT products is mostly driven by the existence of large analytical technology businesses, a growing emphasis on quality, the expansion of the biotechnology sector, and rising R&D spending by pharmaceutical firms.

Read More